Am
J Epidemiol 1988 Jan;127(1):135-44
Excess incidence of treatment of end-stage renal disease in Mexican Americans.
Pugh JA, Stern MP, Haffner SM, Eifler CW, Zapata M.
University of Texas Health Science Center at San Antonio, Department
of Medicine 78284-7873.
Mexican Americans are the second largest minority group in the United
States (8.73 million people according to the 1980 US census) and are known
to have an excess prevalence of obesity and non-insulin-dependent diabetes
mellitus, but similar or lower rates of hypertension when compared with
non-Hispanic whites. To our knowledge, no data are available on incidence
of end-stage renal disease in this population. Using a data base from
the Texas Kidney Health Program, a division of the Texas Department of
Health, and the 1980 US census for the state of Texas, the authors calculated
age-adjusted incidence of treatment of end-stage renal disease in Mexican
Americans, non-Hispanic whites, and blacks for the years 1978-1984. Mexican
Americans and blacks have an excess of treatment of end-stage renal disease
(all etiologies combined) compared with non-Hispanic whites (incidence
ratios of 3 and 4, respectively). For diabetes-related end-stage renal
disease, Mexican Americans have an incidence ratio of 6, while blacks
have an incidence ratio of 4 compared with non-Hispanic whites. For Mexican
Americans, this excess is higher than would be expected on the basis of
their underlying prevalence of diabetes. The incidence of hypertensive
end-stage renal disease in Mexican Americans was 2.5 times higher than
in non-Hispanic whites, which is higher than expected given the lack of
excess in their underlying prevalence of hypertension. The high prevalence
of diabetes in Mexican Americans explains some, but not all, of the excess
of treatment of end-stage renal disease in this population.
Publication Types: Review; Review Literature
PMID: 3276155 [PubMed - indexed for MEDLINE]